Abbott

Company Overview

Abbott is a global healthcare company engaged in the research, development, manufacturing, and commercialization of medical devices, diagnostics, pharmaceuticals, and nutritional products. Its operations are organized into four primary segments: medical devices, diagnostics, established pharmaceuticals, and nutrition. Within the medical devices segment, it focuses on cardiovascular, diabetes care, neuromodulation, and vision care technologies. Its cardiovascular portfolio includes products for cardiac rhythm management, structural heart disease, electrophysiology, and vascular interventions, such as pacemakers, implantable cardioverter defibrillators, heart valves, and related monitoring systems.

Abbott serves worldwide through a broad geographic presence across North America, Europe, Asia-Pacific, South America, and emerging markets. It operates with business activities centered on product lifecycle management, regulatory compliance, and incremental innovation within established therapeutic areas.

Financial Highlights (FY 2025)

Company's Business Segments

• Established Pharmaceutical Products : Gastroenterology, Women’s health, Cardiovascular and metabolic, Pain and central nervous system, and Respiratory drugs and vaccines
• Nutritional Products : Infant formula and follow-on formula, Adult and other pediatric nutritional, and Nutritional used in enteral feeding in health care institutions
• Diagnostic Products : Core laboratory and transfusion medicine systems in the areas of immunoassay, Molecular diagnostics polymerase chain reaction (PCR) instrument systems, Point of care systems, Rapid diagnostics lateral flow testing products in the area of infectious diseases such as SARS-CoV-2, and informatics and automation solutions for use in laboratories
• Medical Devices : Rhythm management, Electrophysiology, Heart failure, Vascular, Structural heart, Continuous glucose and blood glucose monitoring systems, and Neuromodulation